Profile

Quethera Ltd

Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases. The initial focus is on developing therapies to reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve. Quethera is working alongside world leaders in the glaucoma field to design clinical trials capable of examining the efficacy and safety of novel therapies in patients who lose parts of their visual field at an accelerated rate (fast-progressors). The company has expertise in gene therapeutic design and development sufficient to progress its pipeline through preclinical testing and into clinical development.

Status current

Associated Fund Rainbow Seed Fund

Sector Medical / Biotechnology

Website www.quethera.com/

Associated Team Members

Relevant News

Quethera Announces Seed Financing To Develop Gene Therapy Aimed At Preventing Blindness In Glaucoma Patients

Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has…

read more

Best glaucoma poster award to Quethera and Cambridge University at...

Quethera and the Cambridge University Department of Clinical Neurosciences awarded the prize for the...

read more

The Welcome Trust – 2016-03-01

Quethera Ltd, a privately funded gene therapy company based at the Babraham Research Campus...

read more

CAMBRIDGE, UK, 17th September 2015

Quethera announces seed financing to develop gene therapy aimed at preventing blindness in glaucoma...

read more

More Companies in Medical / Biotechnology